Guess Who Picked Corbus Pharmaceuticals (NASDAQ:CRBP) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) reported that Stern Adam K has picked up 2,427,250 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Stern Adam K to a total of 2,427,250 representing a 4.9% stake in the company.
For those not familiar with the company, Corbus Pharmaceuticals Holdings, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the development and commercialization of therapeutics to treat rare or uncommon chronic and serious inflammatory and fibrotic diseases. The Company’s segment is developing and commercializing therapeutics to treat rare life-threatening inflammatory fibrotic diseases. Its product, Resunab, is a synthetic oral endocannabinoid-mimetic drug that is designed to resolve chronic inflammation and halt fibrotic processes without causing immunosuppression. Resunab is being evaluated in approximately three separate Phase II studies for the treatment of cystic fibrosis, systemic sclerosis and skin-predominant dermatomyositis. The United States Food and Drug Administration has granted Resunab Orphan Drug Designation, as well as Fast Track Status, for both cystic fibrosis and systemic sclerosis. Resunab is in Phase II clinical stage for the treatment of Systemic Lupus Erythematosus.
A glance at Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)’s key stats reveals a current market capitalization of 461.19 Million based on 44.44 Million shares outstanding and a price at last close of $9.76 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-22, Cohen picked up 1,340 at a purchase price of $7.64. This brings their total holding to 4,204,562 as of the date of the filing.
On the sell side, the most recent transaction saw Burstein unload 200,000 shares at a sale price of $3.04. This brings their total holding to 3,594,846.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) is Attracting Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) reported that Svlsf Iv, Llc. has picked up 2,579,490 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Svlsf Iv, Llc. to a total of 2,579,490 representing a 26.6% stake in the company.
For those not familiar with the company, KalVista Pharmaceuticals, Inc., formerly Carbylan Therapeutics, Inc., is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The Company has developed a portfolio of small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME). The Company is developing a plasma kallikrein inhibitor, which is administered directly into the eye. The Company is engaged in advancing several product candidates developed from its portfolio into early clinical trials. The Company is progressing additional oral candidates towards regulatory preclinical studies. The Company’s HAE product candidate, KVD818, is an inhibitor of plasma kallikrein. The Company has initiated clinical testing of KVD818 in a Phase I clinical trial. It has completed an open-label single ascending dose Phase I trial in DME patients with KVD001.
A glance at Kalvista Pharmaceuticals Inc. (NASDAQ:KALV)’s key stats reveals a current market capitalization of 72.55 Million based on 9.93 Million shares outstanding and a price at last close of $7.39 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-04-14, Cha picked up 7,364 at a purchase price of $5.00. This brings their total holding to 4,204,562 as of the date of the filing.
On the sell side, the most recent transaction saw Renzi unload 10,000 shares at a sale price of $3.70. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Kalvista Pharmaceuticals Inc. (NASDAQ:KALV) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Hma Acquisition, Inc. is Buying Stage Stores Inc. (NYSE:SSI) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Stage Stores Inc. (NYSE:SSI) reported that Hma Acquisition, Inc. has picked up 1,366,415 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Hma Acquisition, Inc. to a total of 1,366,415 representing a 5.03% stake in the company.
For those not familiar with the company, Stage Stores, Inc. operates specialty department stores mainly in small and mid-sized towns and communities. The Company’s department stores offer a range of brand name and private label apparel, accessories, cosmetics, footwear and home goods. The Company operates approximately 830 specialty department stores in over 40 states under the BEALLS, GOODY’S, PALAIS ROYAL, PEEBLES and STAGE nameplates and a direct-to-consumer business. The Company’s direct-to-consumer business consists of its e-commerce Website and Send program. The Company’s e-commerce Website includes a range of merchandise categories found in its stores, as well as other product offerings. The Company’s in-store Send program allows customers to have merchandise shipped directly to their homes if the preferred size or color is not available in their local store. The Company’s private label portfolio brands are developed and sourced through agreements with third-party vendors.
A glance at Stage Stores Inc. (NYSE:SSI)’s key stats reveals a current market capitalization of 57.88 Million based on 27.17 Million shares outstanding and a price at last close of $2.13 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-06-20, Lundy picked up 4,000 at a purchase price of $5.18. This brings their total holding to 89,807 as of the date of the filing.
On the sell side, the most recent transaction saw Shein unload 5,000 shares at a sale price of $22.42. This brings their total holding to 42,531.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Stage Stores Inc. (NYSE:SSI) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Sacks Bradley J. Picked Up Uluru Inc. (OTCMKTS:ULUR) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Uluru Inc. (OTCMKTS:ULUR) reported that Sacks Bradley J. has picked up 552,960 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Sacks Bradley J. to a total of 552,960 representing a 0.9% stake in the company.
For those not familiar with the company, ULURU Inc. is a specialty pharmaceutical company focused on developing and commercializing a range of wound care and muco-adhesive film products based on its Nanoflex and OraDisc technologies for patients, healthcare professionals and healthcare payers. The Company operates through the research, development and commercialization of pharmaceutical products segment. Utilizing its technologies, three of its products have been approved for marketing in various global markets. Altrazeal Transforming Powder Dressing is based on its Nanoflex technology, which changes the way healthcare providers approach their treatment of wounds. The product is indicated for both exuding acute wounds, such as donor sites, non-healing surgical wounds, and trauma and for chronic wounds, such as venous leg ulcers, diabetic foot ulcers and pressure ulcers. Aphthasol is a drug approved for the treatment of canker sores. OraDisc is developed as an improved drug delivery system for the treatment of canker sores.
A glance at Uluru Inc. (OTCMKTS:ULUR)’s key stats reveals a current market capitalization of 4.03 million based on 62.97 Million shares outstanding and a price at last close of $0.0711 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-29, Wallberg picked up 701,262 at a purchase price of $0.07. This brings their total holding to 825,519 as of the date of the filing.
On the sell side, the most recent transaction saw Oss unload 3,400,000 shares at a sale price of $0.16. This brings their total holding to 8,061,522.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Uluru Inc. (OTCMKTS:ULUR) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Resonant Inc. (NASDAQ:RESN) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Resonant Inc. (NASDAQ:RESN) reported that Longboard Capital Advisors, Llc. has picked up 4,183,459 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Longboard Capital Advisors, Llc. to a total of 4,183,459 representing a 22.47% stake in the company.
For those not familiar with the company, Resonant Inc. is a late-stage development company. The Company creates filter designs for radio frequency (RF) front-ends for the mobile device industry. The RF front-end is the circuitry in a mobile device for analog signal processing and is located between the device’s antenna and its digital baseband. The Company uses a technology called Infinite Synthesized Networks (ISN) to configure and connect resonators, the building blocks of RF filters. The Company uses ISN to develop new classes of filter designs. The Company is also developing a series of single-band surface acoustic wave (SAW) filter designs for frequency bands. The Company is developing multiplexer filter designs for over two bands to address the carrier aggregation (CA) requirements of its customers. In addition, the Company is also developing reconfigurable filter designs to replace multiple filters for multiple bands. The Company is also involved in the development of a filter reconfigurable between three bands.
A glance at Resonant Inc. (NASDAQ:RESN)’s key stats reveals a current market capitalization of 58.51 Million based on 12.44 Million shares outstanding and a price at last close of $4.89 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-04-25, Holmes picked up 8,300 at a purchase price of $2.99. This brings their total holding to 35,300 as of the date of the filing.
On the sell side, the most recent transaction saw Lingren unload 696 shares at a sale price of $4.83. This brings their total holding to 379,473.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Resonant Inc. (NASDAQ:RESN) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Uluru Inc. (OTCMKTS:ULUR) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Uluru Inc. (OTCMKTS:ULUR) reported that Sacks Michael Ivan has picked up 30,050,490 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Sacks Michael Ivan to a total of 30,050,490 representing a 39.0% stake in the company.
For those not familiar with the company, ULURU Inc. is a specialty pharmaceutical company focused on developing and commercializing a range of wound care and muco-adhesive film products based on its Nanoflex and OraDisc technologies for patients, healthcare professionals and healthcare payers. The Company operates through the research, development and commercialization of pharmaceutical products segment. Utilizing its technologies, three of its products have been approved for marketing in various global markets. Altrazeal Transforming Powder Dressing is based on its Nanoflex technology, which changes the way healthcare providers approach their treatment of wounds. The product is indicated for both exuding acute wounds, such as donor sites, non-healing surgical wounds, and trauma and for chronic wounds, such as venous leg ulcers, diabetic foot ulcers and pressure ulcers. Aphthasol is a drug approved for the treatment of canker sores. OraDisc is developed as an improved drug delivery system for the treatment of canker sores.
A glance at Uluru Inc. (OTCMKTS:ULUR)’s key stats reveals a current market capitalization of 4.03 million based on 62.97 Million shares outstanding and a price at last close of $0.0711 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-29, Wallberg picked up 701,262 at a purchase price of $0.07. This brings their total holding to 825,519 as of the date of the filing.
On the sell side, the most recent transaction saw Oss unload 3,400,000 shares at a sale price of $0.16. This brings their total holding to 8,061,522.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Uluru Inc. (OTCMKTS:ULUR) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Bmc Stock Holdings Inc. (NASDAQ:BMCH) is Attracting Smart Money3
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Bmc Stock Holdings In reported that Mfp Investors Llc. has picked up 3,299,000 of common stock as of 2017-03-02.
The acquisition brings the aggregate amount owned by Mfp Investors Llc. to a total of 3,299,000 representing a 4.9% stake in the company.
For those not familiar with the company, BMC Stock Holdings, Inc., formerly Stock Building Supply Holdings, Inc., is a diversified lumber and building materials (LBM) distributor and solutions provider that sells to construction and repair and remodeling contractors. The Company’s operating segments include Mid-Atlantic, Southeast, Texas, Intermountain, West and Mountain West divisions. Its primary products are lumber and lumber sheet goods, millwork, doors, flooring, windows, structural components, such as engineered wood products (EWP), trusses and wall panels, and other exterior products. Additionally, it provides solution-based services to customers, including design, product specification, installation, and installation management services. It offers a range of products sourced through a network of suppliers. It also offers various products, including hardware, wood boards, gypsum, insulation, roofing, siding and flooring. The Company offers scheduling, supplier and subcontractor management, and other services.
A glance at Bmc Stock Holdings Inc. (NASDAQ:BMCH)’s key stats reveals a current market capitalization of 1.37 Billion based on 66.88 Million shares outstanding and a price at last close of $21.15 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-03-16, Oleary picked up 5,000 at a purchase price of $13.78. This brings their total holding to 24,107 as of the date of the filing.
On the sell side, the most recent transaction saw Street unload 30,000 shares at a sale price of $21.00. This brings their total holding to 486,327.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Bmc Stock Holdings Inc. (NASDAQ:BMCH) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
What Management Restructuring Means for iSIGN Media Solutions Inc (OTCMKTS:ISDSF) Shares
iSIGN Media Solutions Inc (OTCMKTS:ISDSF) shares were flat on Wednesday at $0.0898 and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.06 to $0.13. The company has a market cap of $9.76 million at 108.39 million shares outstanding.
iSIGN Media Solutions Inc is a data-focused, software-as-a-service (SaaS) company that is a pioneering leader in gathering point-of-sale data and mobile shopper preferences to generate actionable data and reveal valuable consumer insights. Creators of the Smart suite of products, a patented interactive proximity marketing technology, the company enables brands to deliver targeted messaging, personalized offers and loyalty perks to consumers’ mobile devices in proximity and with real-time proof of redemption.
Its data gathering capabilities provide analytics on price points, typical purchases, in-store dwell time and other shopper metrics that identify emerging consumer behaviors. These insights enable smarter business decisions and provide increased ROI metrics for more transparent marketing. iSIGN delivers relevant, timely messages on an opt-in basis at no charge to consumers, transmitting rich media to consumer mobile devices via Bluetooth and WiFi connectivity in complete privacy as opposed to iBeacons, apps, downloads and required surrendering of personal information. Proven to increase brand engagement and customer loyalty, the company generates preference-based, predictive “clean data” without compromising consumer privacy.
In a press release this week, iSIGN Media Solutions Inc shared that it will be having restructuring of its senior management. Effective March 1, 2017, Joe Kozar, a major shareholder in the company, will be taking on the role of Interim Chief Executive Officer while Alex Romanov, the company’s former Chief Executive Officer, will be undertaking the role of Vice President, Sales and Operations and will retain his Board position.
This change is being implement by the Board in order to allow Alex to fully concentrate upon sales and revenues,” stated Mr. Joe Kozar, iSIGN Media Solutions Inc’s Interim Chief Executive Officer. “With the recent sales of Smart Antennas to our resellers, We Build Apps, LLC and Rich Multimedia Technologies, Inc, it was mutually agreed that iSIGN would best be served by having Alex concentrate his efforts on the sales function.”
These appointments are for an interim period of six months, at which time the Board may elect to extend either of these appointments or appoint new executives to these roles.
I look forward to working with Joe and will support him fully as he undertakes the Chief Executive Officer role and challenges at this pivotal time in iSIGN,” stated Mr. Alex Romanov, iSIGN’s Vice President, Sales and Operations.
Aside from that iSIGN Media Solutions Inc announced that Mr. Prakash Shukla has resigned from the Company’s Board of Directors, effective January 23, 2017 due to an increased work-related schedule, with extensive travel outside of North America.
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.